The forum on “Empowering Anti-Corruption and Governance in Malaysian Medical Device Procurement” addressed crucial challenges related to anti-corruption and governance in the procurement sector. By bringing together authorities and industry stakeholders, the event facilitated a collaborative approach towards enhancing compliance and governance frameworks aligned with the Malaysian Anti-Corruption Commission’s (MACC) regulations.
Summary:
The forum delivered valuable benefits by facilitating knowledge sharing on compliance practices and governance frameworks in medical device procurement, while also providing networking opportunities for professionals to collaborate and exchange best practices. Participants gained a deeper understanding of their responsibilities under the MACC Act and the significance of ethical standards in procurement. Moreover, the event fostered discussions on anti-corruption strategies, promoting a culture of integrity within the medical device industry. Overall, it played a crucial role in advancing effective governance and encouraging the implementation of anti-corruption measures in Malaysia’s medical device procurement landscape.
Key Highlights:
- MACC Session: Presenter elaborated on Section 17A of the Malaysian Anti-Corruption Commission Act 2009, which introduces corporate liability for corruption offenses. The session clarified corporate liability concepts, the elements necessary for its establishment, and how to implement “adequate procedures” to combat corruption. MACC’s initiatives on public education, community engagement, and tax incentives for anti-corruption efforts were also highlighted.
- E-Perolehan MOH: This segment reviewed the evolution of procurement policies in Malaysia, emphasizing transparency, accountability, and achieving the best value for public expenditure. It also tackled common non-compliance issues and outlined the responsibilities of procurement officers in promoting ethical practices.
- Medical Device Authority (MDA): The MDA presented its regulatory framework governing medical devices, covering essential processes such as registration, licensing, and post-market surveillance. The focus was placed on ethical standards, compliance with regulations, and prioritizing patient safety.
- DKSH Framework: DKSH shared its anti-corruption and compliance governance approach, which emphasizes third-party risk management and the importance of employee training and robust reporting mechanisms. The risk-based method ensures the ethical management of supplier relationships while adhering to DKSH’s code of conduct.
